Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas

M. Merli; M. Frigeni; L. Alric; C. Visco; C. Besson; L. Mannelli; A. Di Rocco; A. Ferrari; L. Farina; M. Pirisi; F. Piazza; V. Loustaud-Ratti; A. Arcari; D. Marino; A. Sica; M. Goldaniga; C. Rusconi; M. Gentile; E. Cencini; F. Benanti; M.G. Rumi; V.V. Ferretti; P. Grossi; M. Gotti; R. Sciarra; M.C. Tisi; I. Cano; V. Zuccaro; F. Passamonti; L. Arcaini

doi:10.1634/theoncologist.2018-0331

Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas

M. Merli, M. Frigeni, L. Alric, C. Visco, C. Besson, L. Mannelli, A. Di Rocco, A. Ferrari, L. Farina, M. Pirisi, F. Piazza, V. Loustaud-Ratti, A. Arcari, D. Marino, A. Sica, M. Goldaniga, C. Rusconi, M. Gentile, E. Cencini, F. BenantiM.G. Rumi, V.V. Ferretti, P. Grossi, M. Gotti, R. Sciarra, M.C. Tisi, I. Cano, V. Zuccaro, F. Passamonti, L. Arcaini

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	e720-e729
Journal	Oncologist
Volume	24
Issue number	8
DOIs	https://doi.org/10.1634/theoncologist.2018-0331
Publication status	Published - 2019

Keywords

Diffuse large B-cell lymphoma
Direct-acting antivirals
Hepatitis C virus
R-CHOP
antivirus agent
cyclophosphamide
dasabuvir
doxorubicin
ledipasvir
paritaprevir
prednisone
ribavirin
ritonavir
rituximab
sofosbuvir
vincristine
adult
Article
chronic hepatitis
clinical article
clinical outcome
cohort analysis
diffuse large B cell lymphoma
drug tolerance
female
follow up
genotype
hepatitis C
human
liver toxicity
male
middle aged
multicenter study
overall survival
priority journal
progression free survival
retrospective study
sustained virologic response
treatment response

Cite this

Merli, M., Frigeni, M., Alric, L., Visco, C., Besson, C., Mannelli, L., Di Rocco, A., Ferrari, A., Farina, L., Pirisi, M., Piazza, F., Loustaud-Ratti, V., Arcari, A., Marino, D., Sica, A., Goldaniga, M., Rusconi, C., Gentile, M., Cencini, E., ... Arcaini, L. (2019). Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas. Oncologist, 24(8), e720-e729. https://doi.org/10.1634/theoncologist.2018-0331

Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas. / Merli, M.; Frigeni, M.; Alric, L.; Visco, C.; Besson, C.; Mannelli, L.; Di Rocco, A.; Ferrari, A.; Farina, L.; Pirisi, M.; Piazza, F.; Loustaud-Ratti, V.; Arcari, A.; Marino, D.; Sica, A.; Goldaniga, M.; Rusconi, C.; Gentile, M.; Cencini, E.; Benanti, F.; Rumi, M.G.; Ferretti, V.V.; Grossi, P.; Gotti, M.; Sciarra, R.; Tisi, M.C.; Cano, I.; Zuccaro, V.; Passamonti, F.; Arcaini, L.

In: Oncologist, Vol. 24, No. 8, 2019, p. e720-e729.

Research output: Contribution to journal › Article

Merli, M, Frigeni, M, Alric, L, Visco, C, Besson, C, Mannelli, L, Di Rocco, A, Ferrari, A , Farina, L, Pirisi, M, Piazza, F, Loustaud-Ratti, V, Arcari, A, Marino, D, Sica, A , Goldaniga, M, Rusconi, C, Gentile, M, Cencini, E, Benanti, F, Rumi, MG, Ferretti, VV, Grossi, P, Gotti, M, Sciarra, R, Tisi, MC, Cano, I, Zuccaro, V, Passamonti, F & Arcaini, L 2019, 'Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas', Oncologist, vol. 24, no. 8, pp. e720-e729. https://doi.org/10.1634/theoncologist.2018-0331

Merli, M. ; Frigeni, M. ; Alric, L. ; Visco, C. ; Besson, C. ; Mannelli, L. ; Di Rocco, A. ; Ferrari, A. ; Farina, L. ; Pirisi, M. ; Piazza, F. ; Loustaud-Ratti, V. ; Arcari, A. ; Marino, D. ; Sica, A. ; Goldaniga, M. ; Rusconi, C. ; Gentile, M. ; Cencini, E. ; Benanti, F. ; Rumi, M.G. ; Ferretti, V.V. ; Grossi, P. ; Gotti, M. ; Sciarra, R. ; Tisi, M.C. ; Cano, I. ; Zuccaro, V. ; Passamonti, F. ; Arcaini, L. / Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas. In: Oncologist. 2019 ; Vol. 24, No. 8. pp. e720-e729.

@article{2dc26c04d4ca427a98186d8dee336598,

title = "Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas",

keywords = "Diffuse large B-cell lymphoma, Direct-acting antivirals, Hepatitis C virus, R-CHOP, antivirus agent, cyclophosphamide, dasabuvir, doxorubicin, ledipasvir, paritaprevir, prednisone, ribavirin, ritonavir, rituximab, sofosbuvir, vincristine, adult, Article, chronic hepatitis, clinical article, clinical outcome, cohort analysis, diffuse large B cell lymphoma, drug tolerance, female, follow up, genotype, hepatitis C, human, liver toxicity, male, middle aged, multicenter study, overall survival, priority journal, progression free survival, retrospective study, sustained virologic response, treatment response",

author = "M. Merli and M. Frigeni and L. Alric and C. Visco and C. Besson and L. Mannelli and {Di Rocco}, A. and A. Ferrari and L. Farina and M. Pirisi and F. Piazza and V. Loustaud-Ratti and A. Arcari and D. Marino and A. Sica and M. Goldaniga and C. Rusconi and M. Gentile and E. Cencini and F. Benanti and M.G. Rumi and V.V. Ferretti and P. Grossi and M. Gotti and R. Sciarra and M.C. Tisi and I. Cano and V. Zuccaro and F. Passamonti and L. Arcaini",

note = "Export Date: 11 February 2020 CODEN: OCOLF Correspondence Address: Merli, M.; Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi–ASST Sette Laghi, University of InsubriaItaly; email: michele.merli@asst-settelaghi.it",

year = "2019",

doi = "10.1634/theoncologist.2018-0331",

language = "English",

volume = "24",

pages = "e720--e729",

journal = "Oncologist",

issn = "1083-7159",

publisher = "Wiley Blackwell",

number = "8",

}

TY - JOUR

T1 - Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas

AU - Merli, M.

AU - Frigeni, M.

AU - Alric, L.

AU - Visco, C.

AU - Besson, C.

AU - Mannelli, L.

AU - Di Rocco, A.

AU - Ferrari, A.

AU - Farina, L.

AU - Pirisi, M.

AU - Piazza, F.

AU - Loustaud-Ratti, V.

AU - Arcari, A.

AU - Marino, D.

AU - Sica, A.

AU - Goldaniga, M.

AU - Rusconi, C.

AU - Gentile, M.

AU - Cencini, E.

AU - Benanti, F.

AU - Rumi, M.G.

AU - Ferretti, V.V.

AU - Grossi, P.

AU - Gotti, M.

AU - Sciarra, R.

AU - Tisi, M.C.

AU - Cano, I.

AU - Zuccaro, V.

AU - Passamonti, F.

AU - Arcaini, L.

N1 - Export Date: 11 February 2020 CODEN: OCOLF Correspondence Address: Merli, M.; Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi–ASST Sette Laghi, University of InsubriaItaly; email: michele.merli@asst-settelaghi.it

PY - 2019

Y1 - 2019

KW - Diffuse large B-cell lymphoma

KW - Direct-acting antivirals

KW - Hepatitis C virus

KW - R-CHOP

KW - antivirus agent

KW - cyclophosphamide

KW - dasabuvir

KW - doxorubicin

KW - ledipasvir

KW - paritaprevir

KW - prednisone

KW - ribavirin

KW - ritonavir

KW - rituximab

KW - sofosbuvir

KW - vincristine

KW - adult

KW - Article

KW - chronic hepatitis

KW - clinical article

KW - clinical outcome

KW - cohort analysis

KW - diffuse large B cell lymphoma

KW - drug tolerance

KW - female

KW - follow up

KW - genotype

KW - hepatitis C

KW - human

KW - liver toxicity

KW - male

KW - middle aged

KW - multicenter study

KW - overall survival

KW - priority journal

KW - progression free survival

KW - retrospective study

KW - sustained virologic response

KW - treatment response

U2 - 10.1634/theoncologist.2018-0331

DO - 10.1634/theoncologist.2018-0331

M3 - Article

VL - 24

SP - e720-e729

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 8

ER -

Access to Document

10.1634/theoncologist.2018-0331

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058624960&doi=10.1634%2ftheoncologist.2018-0331&partnerID=40&md5=2bd481a0b0eba12e83e01547e50f78b2

Projects

MAGGIORE - EMERGENZA-URGENZA NELLE GRANDI CRONICITA'

Project: Other project

Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas

Keywords

Cite this

Access to Document

Related content

Projects

MAGGIORE - EMERGENZA-URGENZA NELLE GRANDI CRONICITA'